2022

  1. Wyva

    Long COVID Citizen Scientists: Developing a Needs-Based Research Agenda by Persons Affected by Long COVID, 2022, Ziegler et al

    Abstract Background Long-term health consequences following acute SARS-CoV-2 infection, referred to as post-COVID-19 condition or Long COVID, are increasing, with population-based prevalence estimates for adults at around 20%. Persons affected by Long COVID report various health problems, yet...
  2. Mij

    The effect of water temperature on orthostatic tolerance: a randomised crossover trial, 2022, Lain T Parsons et al

    Abstract Purpose Bolus water drinking, at room temperature, has been shown to improve orthostatic tolerance (OT), probably via sympathetic activation; however, it is not clear whether the temperature of the water bolus modifies the effect on OT or the cardiovascular responses to orthostatic...
  3. Andy

    Exercise Training in Post-COVID-19 Patients: The Need for a Multifactorial Protocol for a Multifactorial Pathophysiology, 2022, Cattadori et al

    Abstract The battle against COVID-19 has entered a new phase with Rehabilitation Centres being among the major players, because the medical outcome of COVID-19 patients does not end with the control of pulmonary inflammation marked by a negative virology test, as many patients continue to...
  4. Andy

    Late-Onset Hypogonadism in a Male Patient with Long COVID Diagnosed by Exclusion of ME/CFS, 2022, Soejima et al

    Abstract After the acute phase of COVID-19, some patients have been reported to have persistent symptoms including general fatigue. We have established a COVID-19 aftercare clinic (CAC) to provide care for an increasing number of these patients. Here, we report the case of a 36-year-old man...
  5. Sly Saint

    Alteration of Cortical Volume and Thickness in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, 2022, Staines et al

    Myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS) patients suffer from neurocognitive impairment. In this study, we investigated cortical volumetric and thickness changes in ME/CFS patients and healthy controls (HC). We estimated mean surface-based cortical volume and thickness from...
  6. Arnie Pye

    Physical fatigue is in the brain as much as in the body, 2022, Robson

    An article from the website Psyche that didn't deserve it's own thread so I hope a mod will move it to where it should have been put. Title : Physical fatigue is in the brain as much as in the body Link : https://psyche.co/ideas/physical-fatigue-is-in-the-brain-as-much-as-in-the-body...
  7. Kalliope

    Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review, Chen et al, 2022

    J Infect Dis. Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review Chen Chen et al Abstract Introduction: This study aims to examine the worldwide prevalence of post COVID-19 condition, through a systematic review and meta-analysis. Methods: PubMed...
  8. Mij

    Vitamin K2 Modulates Mitochondrial Dysfunction Induced by 6-Hydroxydopamine in SH-SY5Y Cells via Mitochondrial Quality-Control Loop, 2022, Henfang et

    Abstract Vitamin K2, a natural fat-soluble vitamin, is a potent neuroprotective molecule, owing to its antioxidant effect, but its mechanism has not been fully elucidated. Therefore, we stimulated SH-SY5Y cells with 6-hydroxydopamine (6-OHDA) in a proper dose-dependent manner, followed by a...
  9. Andy

    USA: Congressionally Directed Medical Research Programs (CDMRP) - [possible ME/CFS funding]

    From a Solve ME email (https://go.solvecfs.org/webmail/192652/244768601/8421fba22dceaa57b85acf39456eef77182e5a5b928514a03a2c9a7fa8ca8530) Webinar for Researchers “CDMRP for ME/CFS: Navigating the Grant Application Process”, 21st April 2022 The FY22 Defense Appropriation provides funding to...
  10. Hutan

    Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection, 2022, Natarajan et al

    https://www.cell.com/med/fulltext/S2666-6340(22)00167-2 Highlights 1.Approximately half of COVID-19 patients shed fecal RNA in the week after infection 2. 4% patients with COVID-19 shed fecal viral RNA 10 months after diagnosis. 3. Presence of fecal SARS-CoV-2 RNA is associated with...
  11. Andy

    Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge, 2022, Lorent et al

    Abstract Background Long-term outcome data of coronavirus disease 2019 (COVID-19) survivors are needed to understand their recovery trajectory and additional care needs. Methods A prospective observational multicentre cohort study was carried out of adults hospitalised with COVID-19 from...
  12. Andy

    Review: Muscle dysfunction in the long coronavirus disease 2019 syndrome: Pathogenesis and clinical approach, 2022, Costa Silva et al

    Abstract In long coronavirus disease 2019 (long COVID-19), involvement of the musculoskeletal system is characterised by the persistence or appearance of symptoms such as fatigue, muscle weakness, myalgia, and decline in physical and functional performance, even at 4 weeks after the onset of...
  13. B

    Microvascular stabilization via blood-brain barrier regulation prevents seizure activity, 2022, Greene et al.

    https://www.nature.com/articles/s41467-022-29657-y Abstract Blood-brain barrier (BBB) dysfunction is associated with worse epilepsy outcomes however the underlying molecular mechanisms of BBB dysfunction remain to be elucidated. Tight junction proteins are important regulators of BBB integrity...
  14. Mij

    Lowered O2 saturation & increased body temp in acute Covid largely predict CFS and affective LC..., 2022, Shihab Al-Hadri et al

    Abstract Background: Long coronavirus disease 2019 (LC) is a chronic sequel of acute COVID-19. The exact pathophysiology of the affective, chronic fatigue and physiosomatic symptoms labeled as physio-affective phenome of LC has remained elusive. Objective: The current study aims to delineate...
  15. Andy

    Detection of Male Hypogonadism in Patients with Post COVID-19 Condition, 2022, Yamamoto et al

    Abstract The pathogenesis and prognosis of post COVID-19 condition have remained unclear. We set up an outpatient clinic specializing in long COVID in February 2021 and we have been investigating post COVID-19 condition. Based on the results of our earlier study showing that “general fatigue”...
  16. Sly Saint

    Developing a model for predicting impairing physical symptoms in children... after SARS-CoV-2 ...: CLoCK Study, 2022, Nugawela, Crawley et al

    Developing a model for predicting impairing physical symptoms in children 3 months after a SARS-CoV-2 PCR-test: The CLoCk Study preprint
  17. Andy

    Risk factors and multidimensional assessment of long COVID fatigue: a nested case-control study, 2022, Margalit et al

    Abstract Background Fatigue is the most prevalent and debilitating long COVID symptom, however risk factors and pathophysiology of this condition remain unknown. We assessed risk factors for long COVID fatigue and explored its possible pathophysiology. Methods Nested case-control study in a...
  18. Wyva

    Updated ME/CFS prevalence estimates reflecting post-COVID increases and associated economic costs and funding implications, 2022, Mirin, Jason et al

    ABSTRACT In this article, we update our earlier analyses of myalgic encephalomyelitis / chronic fatigue syndrome (ME/CFS) economic impact and its National Institutes of Health (NIH) funding versus disease burden, taking into account the anticipated new cases of ME/CFS resulting from COVID-19...
  19. Mij

    CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome, 2022, Mar Guasp et al

    Patients with coronavirus disease 2019 (COVID-19) frequently develop acute encephalopathy and encephalitis, but whether these complications are the result from viral-induced cytokine storm syndrome or anti-neural autoimmunity is still unclear. In this study, we aimed to evaluate the diagnostic...
  20. Sly Saint

    Neuropathology and virus in brain of SARS-CoV-2 infected non-human primates, 2022, Rutkai et al

    Abstract Neurological manifestations are a significant complication of coronavirus disease (COVID-19), but underlying mechanisms aren’t well understood. The development of animal models that recapitulate the neuropathological findings of autopsied brain tissue from patients who died from...
Back
Top Bottom